Literature DB >> 5045959

Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII).

L Lorand, N Maldonado, J Fradera, A C Atencio, B Robertson, T Urayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5045959     DOI： 10.1111/j.1365-2141.1972.tb03455.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Acquired FXIII inhibitors: a systematic review.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 2.  The fibrin stabilizing factor, factor XIII.

Authors:  F Duckert
Journal:  Blut       Date:  1973-03

Review 3.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 4.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

5.  Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.

Authors:  S Lopaciuk; K Bykowska; J M McDonagh; R P McDonagh; W J Yount; C R Fuller; L Cooperstein; A Gray; L Lorand
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

6.  Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII.

Authors:  G R Milner; P J Holt; J Bottomley; J E Maciver
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

7.  Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.

Authors:  L Lorand; P T Velasco; J R Rinne; M Amare; L K Miller; M L Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.